Patient Outcomes after Cardiac Surgery for Carcinoid Heart Disease Are Dependant Upon Successful Cytoreductive Multimodal Treatment and Control of Metastatic Neuroendocrine Disease

#1818

Introduction: Carcinoid Heart Disease (CHD) as a result of long standing carcinoid syndrome is associated with a poor prognosis due to development of valvular incompetence & right heart failure. Cardiac valve surgery is the main therapeutic option.

Aim(s): To assess the long term outcomes of patient undergoing valve surgery as part of a multimodal cytoreductive treatment strategy for metastatic NET.

Materials and methods: Review of patients presenting to the regional NET multidisciplinary meeting over a 5-year period who underwent valve surgery for CHD.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Jaber B, Ramsey E, Cowburn P, Tsang G, Armstrong T,

Keywords: Carcinoid heart disease, surgery,

To read the full abstract, please log into your ENETS Member account.